Fingerstick glucometers on a cost per vial basis for RMR, OKC and musk. Year three funding.

Ended Awarded Last action

Contract number
36C25924N0260
Awardee
Awarding agency
Obligated
$77,461

Award facts

Contract value 100% obligated
$77,460.87 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Oklahoma City, OK 73104, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 -$23,568
Supplemental Agreement for work within scope P00002 -$5,364
Supplemental Agreement for work within scope P00001 -$117
Original award $106,510

About this award

Roche Diagnostics Corporation was awarded a $77.46K firm fixed-price blanket purchase agreement (BPA) call for fingerstick glucometers on a cost-per-vial basis, serving three Veterans Health Administration facilities: the Ralph M. Russ Veterans Medical Center (RMR) in Oklahoma City, the Veterans Medical Center (MUSK), and the Oklahoma City VA Medical Center. This award represents Year Three funding and was issued on May 1, 2024, with a completion date of April 30, 2025. The contract is not subject to a set-aside designation and falls under the scope of services provided through Veterans Integrated Service Network 19 (VISN 19), a regional network within the Department of Veterans Affairs responsible for delivering healthcare to veterans across a multi-state area.

As a child contract to a larger vehicle, this BPA call leverages Roche Diagnostics' established supply relationship with the VA for diagnostic medical devices and reagents. Roche Diagnostics Corporation, a global leader in in vitro diagnostics and point-of-care testing solutions, routinely supplies the federal healthcare system with laboratory equipment, testing systems, and clinical consumables. The provision of fingerstick glucometers supports diabetes management and monitoring across the three VA facilities, enabling veterans to conduct rapid point-of-care glucose testing for improved disease management and clinical outcomes.

Quick answers

Who was awarded contract 36C25924N0260?

36C25924N0260 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on May 1, 2024.

How much is contract 36C25924N0260 worth?

The government has obligated $77,461 on 36C25924N0260.

Is contract 36C25924N0260 an order under another contract?

Yes. 36C25924N0260 is a BPA call under 36C25922A0017, a blanket purchase agreement.

Was contract 36C25924N0260 competed?

The extent of competition for 36C25924N0260 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award